Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Panacea Biotec is an innovation-driven biotechnology company committed to research, development, manufacturing, and marketing of high-quality pharmaceutical formulations, biopharmaceuticals, and vaccines. With a strong focus on addressing unmet medical needs, the company operates in critical therapeutic areas including oncology, nephrology, organ transplantation, diabetes, pain management, and pediatric vaccines. Panacea Biotec aims to deliver accessible and affordable healthcare solutions worldwide, leveraging its advanced R&D capabilities and state-of-the-art manufacturing facilities.
The headquarters serves as the central hub for corporate governance, strategic planning, financial management, R&D oversight, and coordination of national and international business operations.
A modern corporate office equipped with advanced infrastructure to support its administrative, managerial, and strategic functions. While major R&D and manufacturing are at dedicated sites, the HQ oversees these critical operations.
Panacea Biotec fosters a work culture centered on innovation, scientific excellence, quality, and integrity. It encourages collaboration, continuous learning, and a commitment to improving global health outcomes.
The New Delhi headquarters is pivotal for Panacea Biotec's operations, acting as the command center for its diverse activities, from research pipeline management to global market expansion and stakeholder engagement.
Panacea Biotec supports global health through its extensive network spanning product development, manufacturing, and distribution. The company exports its pharmaceutical formulations and vaccines to over 30 countries worldwide, including collaborations with international health organizations like UNICEF and PAHO. Key functions supported globally include international business development, product registration in foreign markets, supply chain management for exports, and participation in global R&D initiatives to develop innovative healthcare solutions.
B-1 Ext. / A-27, Mohan Co-operative Industrial Estate, Mathura Road
New Delhi
Delhi
India
Address: Ambala-Chandigarh Highway, Lalru - 140501, Distt. SAS Nagar (Mohali), Punjab, India
Key manufacturing hub for northern India, supporting large-scale production for global health initiatives and commercial markets.
Address: Village Malpur, P.O. Bhud, Tehsil Baddi, Distt. Solan, H.P. - 173205, India
Significant pharmaceutical manufacturing site, contributing to the company's diverse product portfolio and catering to various therapeutic segments.
Address: Prinzregentenstrasse 68, 81675 Munich, Germany
Facilitates the company's presence and expansion in Europe, managing partnerships and commercial activities for its products in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Panacea Biotec' leadership includes:
Panacea Biotec has been backed by several prominent investors over the years, including:
Panacea Biotec has seen a few key changes in its board and executive leadership over the past year, reflecting strategic alignments and governance enhancements.
Discover the tools Panacea Biotec uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Panacea Biotec commonly uses the email format [firstinitial][lastname]@panaceabiotec.com or [first].[last]@panaceabiotec.com. For general inquiries, specific departmental email addresses are also available on their website.
[firstinitial][lastname]@panaceabiotec.com
Format
rjain@panaceabiotec.com
Example
70%
Success rate
BSE India • February 9, 2024
Panacea Biotec announced its unaudited financial results for the third quarter and nine months ended December 31, 2023. The company reported its performance metrics and outlook....more
BSE India • August 31, 2023
Panacea Biotec Pharma Ltd. announced that its wholly owned subsidiary, Panacea Biotec Germany GmbH, has been awarded a contract for the supply of a Hexavalent Vaccine through PAHO to a UN Agency, for an aggregated value of USD 4.98 million....more
The Economic Times • July 26, 2023
Panacea Biotec partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop broadly protective Betacoronavirus vaccine candidates. CEPI will provide funding of up to USD 12.5 million to support this development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Panacea Biotec, are just a search away.